Buy rating initiated! Discover why this medtech leader with strong growth prospects & dividends is worth your attention.

To enable knowledge sharing for laboratory personnel on technological advancement and best practices made towards assessment of Minimal Residual Disease (MRD) in Acute Leukemia & Myeloma, BD Life ...

Medical devices maker will discuss options for $21bn division with Thermo Fisher, Danaher and other smaller rivals ...

The Financial Times reports today that BD (NYSE: BDX) began discussions with competitors for the sale of its Life Sciences ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment ...

Based in Franklin Lakes, NJ, Becton, Dickinson and Company, commonly known as BD, is a medical technology company engaged principally in the development, manufacture and sale of medical devices ...

BD treated the first subject in the trial with GalaFLEX LITE Scaffold for reducing the recurrence of CC during breast revision surgeries.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was downgraded by StockNews.com from a “buy” rating to a “hold” ...

The Food and Drug Administration has identified a Class I recall of Becton, Dickinson and Company BD Alaris Systems Manager and BD Care Coordination Engine Infusion Adapters due to reports that ...

Becton Dickinson (BDX) announced the first patient treated in an investigational device exemption clinical trial intended to advance BD’s ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Fortune's ...

River Road Asset Management, an investment management company released its “River Road Large Cap Value Select Fund” Q4 2024 ...